Induction of complete remission using single agent clofarabine in a patient with primary refractory acute myeloblaste leukemia.

Author(s): Douer D, Watkins K, Levine AM, Weiss JM, Marshall LC, Craig AR

Affiliation(s): Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. douer_d@ccnt.hsc.usc.edu

Publication date & source: 2003-12, Leuk Lymphoma., 44(12):2135-6.

Publication type: Case Reports

Refractory AML patients have a very poor prognosis. Therefore, rationally designed new therapies, including clofarabine, are being investigated as potential treatments for this patient population. This is a case report of a patient with primary refractory AML who was treated with clofarabine and achieved a complete response.